Language selection

Search

Details for: JENTADUETO

Company: BOEHRINGER INGELHEIM (CANADA) LTD LTEE

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02403250JENTADUETOLINAGLIPTIN; METFORMIN HYDROCHLORIDE2.5 MG; 500 MGTABLETORAL
02403269JENTADUETOLINAGLIPTIN; METFORMIN HYDROCHLORIDE2.5 MG; 850 MGTABLETORAL
02403277JENTADUETOLINAGLIPTIN; METFORMIN HYDROCHLORIDE2.5 MG; 1000 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) inhibitors - Assessing the risk of joint pain (arthralgia)
Summary Safety Review - Dipeptidylpeptidase-4 (DPP-4) Inhibitors - Assessing the Potential Risk of Heart Failure
Summary Safety Review - DPP-4 inhibitors (gliptins) - Assessing the Potential Risk of Gastrointestinal Blockage (Gastrointestinal Obstruction)
Summary Safety Review - Incretin-Based Therapies - Assessing the Potential Risk of Pancreatic Cancer
Summary Safety Review - Dipeptidylpeptidase-4 inhibitors - Assessing the potential risk of a skin reaction (bullous pemphigoid)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: